Intervention Protocol

You have free access to this content

Neuromuscular blocking agents for patients with acute respiratory distress syndrome

  1. Guang-Ying Zhuo1,
  2. Qing He2,*,
  3. Li J Yang1,
  4. Guan J Liu3,
  5. Jonathan N Rajan4

Editorial Group: Cochrane Anaesthesia Group

Published Online: 23 JAN 2014

DOI: 10.1002/14651858.CD010924


How to Cite

Zhuo GY, He Q, Yang LJ, Liu GJ, Rajan JN. Neuromuscular blocking agents for patients with acute respiratory distress syndrome (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010924. DOI: 10.1002/14651858.CD010924.

Author Information

  1. 1

    West China Hospital, Sichuan University, Emergency Department, Chengdu, China

  2. 2

    The Third People's Hospital of Chengdu, Department of Respiratory Medicine, Chengdu, Sichuan, China

  3. 3

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre, Chengdu, Sichuan, China

  4. 4

    Manchester Royal Infirmary, Anaesthetics and Intensive Care, Manchester, UK

*Qing He, Department of Respiratory Medicine, The Third People's Hospital of Chengdu, Qinglong, 37#, Chengdu, Sichuan, 610031, China. hq_1919@126.com.

Publication History

  1. Publication Status: New
  2. Published Online: 23 JAN 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

We will assess the effectiveness and safety of using neuromuscular blocking agents within 48 hours of initiation of mechanical ventilation for ARDS patients.